Does Wegovy Cause Mood Changes?
Wegovy (semaglutide) carries warnings for potential mental health effects, including mood changes. The prescribing label lists suicidal thoughts or behavior as a serious risk, with post-marketing reports of depression and mood alterations in patients using GLP-1 agonists like semaglutide.[1] Clinical trials showed low rates—less than 1% for depression—but real-world data from sources like the FDA's FAERS database include thousands of mood-related adverse events, such as anxiety, irritability, and suicidal ideation.[2][3]
Patients report mood swings, low mood, or emotional blunting on forums like Reddit and Drugs.com, often linking them to rapid weight loss, appetite suppression, or gut-brain axis effects from GLP-1 drugs.[4]
What Do Clinical Studies Show?
In STEP trials for weight loss (Wegovy's basis), mood disorders occurred in 0.1-0.4% of Wegovy users versus 0.2% on placebo, not statistically higher.[5] However, a 2024 Danish study of 1.8 million GLP-1 users found a 58% increased risk of suicidal thoughts compared to other weight-loss drugs like bupropion.[6] No direct causation proven; factors like obesity-related depression or unmasking pre-existing issues may contribute.
Why Might Mood Changes Happen?
Semaglutide crosses the blood-brain barrier, influencing reward centers and serotonin pathways, potentially mimicking antidepressant effects or causing dysphoria during dose escalation.[7] Nausea, fatigue, or nutritional deficits from calorie restriction can indirectly worsen mood. Thyroid C-cell tumors in rodents (boxed warning) raise rare concerns about broader endocrine mood impacts, though not seen in humans.[1]
How Common Are Reports and Who’s at Risk?
FDA data through 2024 logs over 5,000 psychiatric events for semaglutide products (Ozempic/Wegovy), with mood changes in ~10-15% of those.[3] Higher risk in patients with depression history, bipolar disorder, or abrupt dose changes. Women and younger adults report more cases anecdotally.[2]
What Should Patients Watch For?
Monitor for persistent sadness, anxiety, panic, or suicidal thoughts—discontinue and seek immediate care if severe. Label advises screening for mental health history before starting.[1] Providers often pair Wegovy with therapy or antidepressants.
Alternatives Without Strong Mood Warnings?
| Drug | Mood Risk Profile | Key Differences |
|------|-------------------|-----------------|
| Zepbound (tirzepatide) | Similar GLP-1 warnings; fewer mood reports in trials [8] | Dual GLP-1/GIP; faster weight loss |
| Saxenda (liraglutide) | Established depression risk (1-2% in trials) [9] | Daily injection; less potent |
| Phentermine | Stimulant; can cause anxiety/euphoria [10] | Short-term; cheaper generic |
| Orlistat (Xenical) | Minimal psychiatric effects [11] | Blocks fat absorption; GI side effects |
Switching meds or adding SSRIs helps some patients.
[1] Wegovy Prescribing Information (FDA)
[2] JAMA Network Open: GLP-1 Agonists and Suicidality (2024)
[3] FDA FAERS Public Dashboard
[4] Drugs.com Wegovy Reviews
[5] NEJM: STEP 1 Trial (2021)
[6] Nature Medicine: Semaglutide and Suicidality (2024)
[7] Frontiers in Psychiatry: GLP-1 Brain Effects (2023)
[8] Zepbound Label (FDA)
[9] Saxenda Label (FDA)
[10] Phentermine Label (FDA)
[11] Xenical Label (FDA)